Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Fosun Pharma (SSE: 600196; HKEX: 02196) today announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited. ("Yao Pharma"), Shanghai Fosun Pharmaceutical Industrial Development Company...
Stern School of Business at NYU Abu Dhabi releases inaugural Financial Center Competitiveness Index
Results rank New York, London, and Singapore as the top three global financial centers Abu Dhabi, Dubai, Riyadh, and Doha all feature in the top 30, underscoring the GCC's growing role in global finance First major publication of the Institute for...
ISLAND HOSPITAL NAMED MALAYSIA'S FIRST FLAGSHIP MEDICAL TOURISM HOSPITAL
GEORGETOWN, Malaysia, Dec. 9, 2025 /PRNewswire/ -- Island Hospital is the winner of Malaysia's first Flagship Medical Tourism Hospital (FMTH) programme, a recognition of its consistent standards in care, safety and patient experience for...
Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025
SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for cancer and immunological diseases, announced new data from its hematology portfolio at the 67th American Society of...
VINSSEN and ILDO F&C Form Exclusive Alliance to Advance Composite Bipolar Plate Technology for Hydrogen Systems
Joint innovation targets lower costs, higher durability, and broader applications across the hydrogen value chain SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- VINSSEN, a maritime decarbonization technology company specializing in hydrogen fuel...
AI Infrastructure Company EverMind's EverMemOS Aims to Give AI Agents Durable, Coherent, and Continuously Evolving "Souls"
SAN MATEO, Calif., Dec. 9, 2025 /PRNewswire/ -- AI infrastructure company EverMind has announced a major milestone in long-term memory research with its newly released EverMemOS achieving 92.3% accuracy on LoCoMo and 82% on LongMemEval-S—two of the...
Phase II Data of Cadonilimab Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer Presented at ESMO Asia 2025
HONG KONG, Dec. 9, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that data from the Phase II study (COMPASSION-25) for its first-in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, in combination with SOX regimen...
ASPEED Technology Wins GSA Best Financially Managed Semiconductor Company Award
HSINCHU, Dec. 9, 2025 /PRNewswire/ -- ASPEED Technology, the world's leading provider of Baseboard Management Controller (BMC) SoCs, today announced that it has been awarded the 2025 "Best Financially Managed Semiconductor Company Award" (Achieving...
GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy
YONGIN, South Korea, Dec. 9, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) fragmentation patterns in 1,154 healthy individuals has been published in...
Global Fashion Agenda Grows Efforts to Combat Textile Waste through New Initiative in Türkiye
ISTANBUL, Turkey, Dec. 9, 2025 /PRNewswire/ -- Today, Global Fashion Agenda (GFA) announced the launch of the Circular Fashion Partnership: Türkiye, a new initiative that aims to support the development of a circular textile system in the country by...